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Summary The absorption of iron from Spatone Iron-Plus has been investigated in pregnant women
with iron deficiency anaemia. A total of 25 mg Fe was taken and absorption determined
from the increase in serum iron concentration during a period of 3 h. Mean absorption was
28%, significantly higher than in nonpregnant, nonanaemic women (14%). These studies
demonstrate that Spatone provides an alternative to the standard ferrous sulphate tablet for
prevention of iron deficiency in pregnancy. As only lower doses of iron are required, the
unpleasant side-effects of iron therapy are largely avoided.
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Introduction
Most of the 3–4 g iron in the human body is found in
haemoglobin, the oxygen carrying pigment of the red
blood cell. There are smaller amounts in myoglobin, in
muscle and even less in the multitude of iron containing
proteins responsible for oxygen utilization in all cells. A
variable amount of ‘storage iron’ is found in the tissues as
ferritin and haemosiderin. For a review of iron metabolism
see Sherwood et al. (1998). In men, iron losses are limited
to about 1 mg Fe/day, regardless of the amount of iron in
the body. Menstruation increases daily iron losses in
women to 1.4 mg and the net loss of iron in pregnancy
corresponds to a mean daily loss of nearly 3 mg/day
(British Nutrition Foundation, 1995). Infants are born
with high levels of haemoglobin and storage iron but after
6 months of age iron requirements are high, relative to
body weight because of the demand for iron caused by
rapid growth. The iron content of the body is regulated by
variation in the amount of iron absorbed from the diet.
Western diets usually contain about 10–15 mg Fe and
about 10% is retained in the body. This level of intake is
usually adequate for men but – although iron absorption
percentage increases with decreasing levels of storage iron
– women and children must generally obtain larger
amounts of iron from a smaller dietary intake.
Iron deficiency, defined as an absence of storage iron, is
therefore relatively common in children and women of
childbearing age. The level of storage iron may be
estimated by measuring the serum ferritin concentration.
Concentrations of <15 lg/l indicate the absence of storage
iron and a value of 300 lg/l is equivalent to iron stores of
about 2 g (the maximum normally found). Hallberg et al.
(1993) considered that the best indicator of iron deficiency
was a ferritin concentration of <16 lg/l, and have
concluded that approximately 30% of young women in
Europe and North America are iron deficient. However,
improving specificity by the application of multiple meas-
ures (i.e. a low serum ferritin and a low transferrin
saturation) suggested that approximately 12% of young
women in North America may be iron deficient (Cook
et al., 2001). If iron losses continue, iron deficiency
anaemia will develop (Baynes, 1994). Iron deficiency
anaemia causes tiredness and breathlessness, and is
associated with other physical and behavioural abnor-
malities, particularly in childhood. In North America and
Europe the incidence of iron deficiency anaemia in women
is about 10% and in parts of the developing world the
incidence is over 50% (DeMaeyer et al., 1985).
Iron deficiency anaemia is the most common haemato-
logical problem in pregnancy. In some hospitals prophy-
lactic iron is given to all women during pregnancy but
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there is no agreement about the desirability of this practice
and in other hospitals iron is only prescribed when
anaemia develops (Hibbard, 1988; Horn, 1988). Iron
must be added to infant formulas and follow-on formulas
(except those used only during the first 4 months of life) to
meet the composition given in the European Community
Directive 91/321/EEC. In the UK, white flour is supple-
mented to increase the iron content to that of wholemeal
flour (Department of Health and Social Security, 1981).
This iron is poorly available and there is little evidence
about its efficacy (Department of Health and Social
Security, 1981). Universal fortification of food may have
undesirable consequences for the one in 200 people in
Northern European populations with genetic haemochro-
matosis, a disorder in which too much iron is absorbed
(Olsson et al., 1997). However, the prevalence of clinical
haemochromatosis is much lower than this (McCune
et al., 2002) and the significance of fortification for
increasing morbidity because of iron overload is not
known.
Tonics and food supplements containing iron are widely
available and have been used for centuries. Such supple-
ments should ideally contain iron that is highly available,
should not cause side-effects and should not be absorbed
by those with high levels of storage iron who do not need
additional iron. Spatone Iron-Plus is a naturally occurring
spa water from Trefriw Wells in Gwynedd (Wales), which
contains approximately 0.21 mg of iron/ml as ferrous
sulphate in solution. The water has been taken as a tonic
since Victorian times. Iron absorption from Spatone Iron-
Plus was measured in a whole body counter after labelling
the Spatone with 59Fe ferrous sulphate. Absorption studies
were carried out in 13 subjects. Mean absorption from
3 mg Spatone Iron-Plus taken in empty stomach was
23%. Absorption was related to body iron stores as
assessed by serum ferritin. In subjects with a serum ferritin
concentration of <10 lg/l, absorption was approximately
40% but was <10% in subjects with ferritin concentra-
tions of approximately 200 lg/l. This study indicated that
Spatone Iron-Plus provides iron in a highly bio-available
form (Worwood et al., 1996).
The aim of the present study was to measure the
absorption of iron from Spatone in pregnant, anaemic
subjects and to assess its potential value in preventing iron
deficiency anaemia.
Subjects and methods
The serum iron response to Spatone was measured in 12
women in the third trimester of pregnancy with iron
deficiency anaemia (Hb <10.5 g/dl and serum ferritin
<15 lg/l). There is some variation in serum iron concen-
tration with time in the absence of food or iron intake and
this was assessed in six pregnant women (third trimester)
with iron deficiency anaemia (Hb <10.5 g/dl and serum
ferritin <15 lg/l) who took deionized water. In order to
compare the serum iron response with that in women
with normal iron stores who were not anaemic, Spatone
was administered to 15 women aged 20–45 years who
were neither pregnant nor anaemic, and deionized water
to another nine women. These women were volunteers
from the staff at the Royal Glamorgan Hospital with
Hb > 11.5 g/dl and serum ferritin > 15 lg/l.
The study protocol was approved by the Ethics Com-
mittee of Bro Taf Health Authority. Potentially pregnant
and anaemic participants were identified from notes and
consultation with the respective clinicians. They were
given oral and written information and gave informed
consent. All subjects fasted from midnight on the day
before the test. They were allowed to drink water but not
tea or coffee (which impair iron absorption) or juice drinks
which may enhance iron absorption. Each participant
received a payment of £40 to compensate for the time and
inconvenience of the study.
At the outset, the women were weighed and a baseline
venous blood sample was drawn to obtain a blood count
and measure serum iron concentration, total iron binding
capacity (TIBC) and serum ferritin prior to the adminis-
tration of the fluid.
Either the contents of sachets of Spatone (120 ml
containing 25 mg Fe) or the sachets of deionized water
(120 ml at the same pH of 2.9) were taken. Up to 100 ml
of deionized water could be taken afterwards if required, to
cleanse the palate. Spatone provided both the product and
deionized water packed in sachets under nitrogen to
prevent oxidation of iron. This is the usual market
formulation. These sachets had random numbers attached
at the University of Glamorgan (LM). Subjects were also
allocated one of the random numbers. Participants and
samples were paired and the sample identified at the end of
the study (i.e. it was double-blind).
Further venous blood samples (5 ml, clotted) were
taken by a midwife (GH) at 30 min, 1, 2 and 3 h using a
butterfly needle. Subjects remained seated or lying down
during the study as far as possible. During this time they
did not drink tea or coffee, but were allowed to drink water
ad libitum an hour after the initial sample was taken.
Dextrose and additional food were available if anyone
felt faint. Withdrawal from the study might occur at any
time if the participant so wished, or if there were clinical
indications for doing so. Food was provided for every
participant after the last blood sample was taken.
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Blood was collected in labelled, serum sample bottles
with clot retractant. The bottles were collected daily and
transported to the Haematology Department at the Uni-
versity of Wales College of Medicine. Serum iron concen-
tration and TIBC were measured (Worwood, 2001), and
serum ferritin by immunoassay (Elecsys 2010 system;
Roche Diagnostics, Lewis, UK). Percentage iron absorption
was calculated from the maximum increase in serum iron
concentration as described by Ekenved et al. (1976). The
maximum value occurred 2 or 3 h after taking Spatone.
The mean change in serum iron concentration between 0
and 3 h for women taking water was subtracted from the
increments after Spatone for each group.
The data were entered into an electronic format at the
College of Medicine, and at the end of the data collection
period were supplied to the University of Glamorgan. The
samples were decoded and the analysis completed.
Results
Mean values for body weight, serum iron, transferrin
saturation and serum ferritin concentration are shown in
Table 1. Mean body weight did not differ for the pregnant
and nonpregnant women but the anaemic women had
low serum iron, transferrin saturation and serum ferritin
concentrations compared with the nonpregnant women.
Changes in serum iron concentration in women taking
Spatone or water are illustrated in Figure 1. The mean
increment in serum iron concentration for nonpregnant
women taking water was 1.4 lmol/l and for those taking
Spatone was 11.7 lmol/l. For pregnant, anaemic women
the increment was 0.6 mol/l for those taking water and
15.3 lmol/l for those taking Spatone. Before allowing for
blood volume changes in pregnancy, the percentage iron
absorption was 13.8% in the nonpregnant women and
19.6% in the anaemic, pregnant women (P ¼ 0.042, two
sample t-test). After correction for the increase in plasma
volume (a factor of 1.44 for late pregnancy; Lange &
Dynesius, 1972) absorption was 28.2% in pregnant
women significantly higher than in nonpregnant women
(P < 0.001, two sample t-test).
There was no relationship between percentage iron
absorption and weight in either group of women. Fur-
thermore, there was no relationship between iron absorp-
tion and transferrin saturation or serum ferritin
concentration in either group. This was because groups
were selected to be anaemic or nonanaemic. Numbers
were small and there was relatively little variation in iron
status within each group.
Discussion
Pregnancy leads to a mean loss of about 680 mg Fe. This
is because of the following iron needs: 170 mg for basal
losses, 270 mg to the foetus, 90 mg with the placenta and
umbilical cord, and about 150 mg as peripartum iron
losses (Hardman & Limbird, 2001). These additional
requirements are not easily met from the diet, and women
Table 1. Iron absorption in women
taking Spatone
Variable
Nonanaemic,
nonpregnant women
Anaemic pregnant
women
Water Spatone Water Spatone
Number 6 15 12 12
Weight (kg) 84 ± 33* 74 ± 19* 74 ± 16* 75 ± 23*
Serum ferritin (lg/l) 68 ± 67* 36 ± 11* 6 ± 2* 7 ± 2*
Transferrin saturation (%) 21 ± 10* 27 ± 16* 7 ± 5* 8 ± 4*
Percentage of Fe absorption 0 13.8 ± 7* 0 19.6 ± 7.0*
Percentage of Fe absorption
(corrected for the increased
plasma volume in pregnancy)
0 – 0 28.2 ± 10.0*
*Values are given as mean ± SD.
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Figure 1. Change in serum iron concentration with time (the
response in pregnant, anaemic women, one drinking deionized
water and one Spatone).
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who enter pregnancy with a serum ferritin concentration
of <50 lg/l are at a high risk of developing iron deficiency
anaemia (Romslo et al., 1983) compared with women
with serum ferritin >80 lg/l.
Oral iron is offered to women with iron deficiency
anaemia but this is sometimes difficult to distinguish from
the physiological anaemia of pregnancy, a consequence of
the expansion in plasma volume. Serum ferritin concen-
trations are also affected by the changes in plasma
volume. Transferrin saturation (the ratio of serum iron
and total iron binding capacity) should provide an
indicator that is unaffected by changes in plasma volume,
but tends to be low in pregnancy because the increased
iron requirements cause a greater rate of iron clearance
from the plasma. However, the relationship between the
maximum increase of serum iron and the absorption of
iron was found to be the same in normal and iron deficient
subjects (Ekenved et al., 1976).
In the first trimester, iron requirements are less than
those of menstruating women (at the basal requirement of
0.8 mg daily) but the daily requirement increases to about
4 mg in the second trimester and 7 mg in the last
trimester. All studies of iron absorption in pregnancy show
that there is a striking and appropriate increase in
percentage absorption as pregnancy proceeds (British
Nutrition Foundation, 1995). Studies with radioactive
and stable isotopes of iron have shown increases of 5–10-
fold for the third trimester compared with the first
trimester. If the dietary iron intake of about 12 mg/day is
sufficient to provide an adequate iron absorption of about
1 mg/day in the first trimester then a 5-fold increase in
absorption should satisfy the requirements during the
second and third trimester. However, in many cases this is
not achieved, iron balance is negative (Hardman &
Limbird, 2001) and supplementation is required if anaemia
is to be avoided.
The standard dose of ferrous sulphate for prophylaxis is
65 mg Fe/day and even at a conservative estimate of 10%
absorption, this provides sufficient iron to prevent iron
deficiency anaemia. However, many women do not
continue with oral iron because of side-effects including
nausea, epigastric pain, diarrhoea in subjects with inflam-
matory bowel disease and constipation. Side-effects are
much more frequent when three tablets are taken each
day (Hardman & Limbird, 2001). The smaller amount of
iron in Spatone provides a higher percentage absorption
than the larger doses of ferrous sulphate and the incidence
of side-effects should be low. None of the participants
reported any adverse effects. A previous study indicated
that in women with iron deficiency (serum ferritin
<15 lg/l), a mean of 34% absorption was achieved from
3 mg Fe and in this study, a mean absorption of 28%
(range 5–40%) from 25 mg Fe was found. A recent study
of Spatone taken in weeks 22–28 of pregnancy by women
who had not complied with the standard ferrous sulphate
prophylaxis for anaemia has been reported. In women
taking Spatone, the fall in serum ferritin concentrations
was significantly less than in women not taking iron and
there were no differences in the frequency of dyspepsia
(McKenna et al., 2002).
During pregnancy, a mean iron absorption of 2.5 mg/
day is required if iron stores after birth are not to be
reduced below the level of storage iron before pregnancy.
To avoid reducing iron stores during later pregnancy,
about 4 mg Fe/day is required. It is reasonable to assume
that at least 1 mg Fe/day is provided from the diet
throughout pregnancy. Mean absorption from two sachets
of Spatone (10 mg Fe), in empty stomach, will be between
28% (25 mg dose) and 34% (3 mg dose), and will provide
another 3 mg iron for women with low iron stores. This
should provide an adequate iron supply for most women.
Women who enter pregnancy with iron deficiency
anaemia, or an absence of storage iron (serum ferritin
<15 lg/l) will require supervision and higher doses of
supplemental iron to increase the level of storage iron.
Doubling the daily dietary iron intake of 11 mg by
supplementation should prevent the development of iron
deficiency anaemia in most women. This may be provided
by taking two sachets of Spatone (10 mg Fe) daily.
Acknowledgements
This study was partially funded by Spatone iron+, Trefriw
Wells Spa (Gwynedd, Wales).
References
Baynes R.D. (1994) Iron Deficiency. In, Iron metabolism in
health and disease (eds by J. H. H. J. W. Brock, M. J. Pippard &
L. W. Powell), pp. 189–225. W.B. Saunders Company Ltd.
British Nutrition Foundation (1995) Report of the Task Force.
Iron – Nutritional and Physiological Significance, Chapman
and Hall, London.
Cook J.D., Skikne B., Lynch S.R. & Reusser M.E. (2001) Esti-
mates of iron sufficiency in the US population. Blood 68,
726–761.
DeMaeyer E., Adiels-Tegman M. & Rayston E. (1985) The pre-
valence of anemia in the world. World Health Statistics Quar-
terly 38, 302–316.
Department of Health and Social Security (1981). Nutritional
Aspects of Bread and Flour. Reports on Health and Social Sub-
jects. Vol. 23, London, HMSO.
Ekenved G., Norrby A. & Solvell L. (1976) Serum iron increase as
a measure of iron absorption – studies on the correlation with
Iron absorption in pregnancy230
 2003 Blackwell Publishing Ltd., Clin. Lab. Haem., 25, 227–231
total iron absorption. Scandinavian Journal of Haematology S28,
31–49.
Hallberg L., Bengtsson C., Lapidus L., Lindstedt G., Lundberg
P.-A. & Hulten L. (1993) Screening for iron deficiency: an
analysis based on bone-marrow examinations and serum
ferritin determinations on a population sample of women.
British Journal of Haematology 85, 787–798.
Hardman J.G. & Limbird L.E. (2001) Goodman & Gilman’s the
Pharmacological Basis of Therapeutics, 10th edn, McGraw-Hill,
New York.
Hibbard B.M. (1988) Iron and folate supplements during preg-
nancy: supplementing everyone treats those at risk and is cost
effective. British Medical Journal 297, 1324, 1326.
Horn E. (1988) Iron and folate supplements during pregnancy –
supplementing everyone treats those at risk and is cost-effect-
ive. British Medical Journal 297, 1325, 1327.
Lange D.R. & Dynesius R. (1972) Blood volume changes during
normal pregnancy. Clinics in Haematology 2, 433–451.
McCune C.A., Al-Jader L.N., May A., Hayes S.L., Jackson H.A. &
Worwood M. (2002) Hereditary haemochromatosis: only 1%
of adult HFE C282Y homozygotes in South Wales have a
clinical diagnosis of iron overload. Human Genetics 111, 538–
543.
McKenna D., Dornan J., Haggen S., McCrum E. & Lappin
T.R.J. (2003) A randomised trial investigating an iron rich
natural mineral water as a prophylaxis against iron defi-
ciency in pregnancy. Clinical and Laboratory Haematology,
25, 99–103.
Olsson K.S., Vaisanen M., Konar J. & Bruce A. (1997) The effect
of withdrawal of food iron fortification in Sweden as studied
with phlebotomy in subjects with genetic hemochromatosis.
European Journal of Clinical Nutrition 51, 782–786.
Romslo I., Haram K., Sagan N. & Augensen K. (1983) Iron
requirements in normal pregnancy as assessed by serum fer-
ritin, serum transferrin saturation and erythrocyte proto-
porphyrin determinations. British Journal of Obstetrics
and.Gynaecology 90, 101–107.
Sherwood R.A., Pippard M.J. & Peters T.J. (1998) Iron home-
ostasis and the assessment of iron status. Annals of Clinical
Biochemistry 35, 693–708.
Worwood M. (2001) Iron deficiency anaemia and iron overload.
Dacie and Lewis Practical Haematology. Eds Lewis S.M.,
Bain B.J. & Bates I. pp. 125–128. Churchill Livingstone, London.
Worwood M., Evans W.D., Villis R.J. & Burnett A.K. (1996) Iron
absorption from a natural mineral water (Spatone Iron-Plus).
Clinical and Laboratory Haematology 18, 23–27.
G. Halksworth et al. 231
 2003 Blackwell Publishing Ltd., Clin. Lab. Haem., 25, 227–231
